5V7.F VENTRIPOINT DIAGNOSTICS

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
0.0345 EUR
Close of Nov 11, 2026
0.0310 0.0940
Market cap
EUR 6.72M
P/E
-
P/B
6.73x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 5V7.F undervalued?

Graham number

The Graham number of VENTRIPOINT DIAGNOSTICS cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

VENTRIPOINT DIAGNOSTICS fundamental analysis

No fundamental analysis for VENTRIPOINT DIAGNOSTICS yet.

VENTRIPOINT DIAGNOSTICS stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About VENTRIPOINT DIAGNOSTICS

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), which transforms standard 2D and 3D echocardiography and a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides VMS+ software, 2D an…

Full company profile